1,721,496 research outputs found
Editorial comment on: the relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms.
No full textFisiopatologia. Iperplasia Prostatica Benigna. In Manuale pratico di orientamento diagnostico.
No full textRe: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512-8.
No full text
Re: Iori et al.: Bipolar transurethral resection of the prostate: clinical and urodynamic evaluation.
No full text
Re: Knutson T, Pettersson S, Dahlstrand C. The use of biodegradable PGA stents to judge the risk of post-TURP incontinence in patients with combined bladder outlet obstruction and overactive bladder. Eur Urol 2002;42 : 262-7
No full textComparison of peripherally acting substance for treatment of detrusor overactivity: What is new; what is in the pipeline?
No full textOveractive bladder is an highly prevalent syndrome involving up to 17% of the population in both western Europe and US and is often associated with detrusor overactivity. Significant improvement in the management of this condition has recently occurred cause the availability of new drugs. Methods: The Medline database has been extensively searched. Research has also involved industrial and private databases available online and specialised in the development of new drugs. Results: Antimuscarinics remain the gold standard in the management of detrusor overactivity although the condition mostly goes undiagnosed in non neurogenic patients suffering from overactive bladder syndrome. A number of receptors other than muscarinics have been investigated as possible new targets although no novel effective drugs have been yet developed. Conclusion: Antimuscarinic drugs dominate medical treatment of symptoms and signs associated with detrusor overactivity although new drugs will hopefully be available in the future based on alternative pathophysiological mechanism. © 2004 Elsevier B.V. All rights reserved
- …
